Sickle cell trait worsens oxidative stress, abnormal blood rheology, and vascular dysfunction in type 2 diabetes

Diabetes Care

Volumn 38, Issue 11, 2015, Pages 2120-2127

  Diaw, Mor ^a   Pialoux, Vincent ^b,c,d   Martin, Cyril ^b,d   Samb, Abdoulaye ^a   Diop, Saliou ^a   Faes, Camille ^b,d   Mury, Pauline ^b,d   Diop, Niama Sall ^a   Diop, Säid Norou ^e   Ranque, Brigitte ^d,f,g   Mbaye, Mäimouna Ndour ^e   Key, Nigel S ^h   Connes, Philippe ^b,c,d  

^a UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^b UNIVERSITÉ LYON 1   (France)

^c INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^d Sorbonne   (France)

^e Centre Hospitalier Universitaire Dakar   (Senegal)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME METABOLISM; FEMALE; FLOW MEDIATED DILATION; FLOW RATE; HUMAN; INFLAMMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PULSE RATE; SICKLE CELL TRAIT; BLOOD; FLOW KINETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PULSE WAVE; RISK FACTOR; SENEGAL; VASCULAR DISEASE;

ADULT; BLOOD VISCOSITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULSE WAVE ANALYSIS; RHEOLOGY; RISK FACTORS; SENEGAL; SICKLE CELL TRAIT; VASCULAR DISEASES;

EID: 84962338809     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0699     Document Type: Article

References (39)

1. Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol 2012;10:19-32.
2. Yamamoto Y, Yamamoto H. RAGE-mediated inflammation, type 2 diabetes, and diabetic vascular complication. Front Endocrinol (Lausanne) 2013;4:105.
3. Mbanya JC, Assah FK, Saji J, Atanga EN. Obesity and type 2 diabetes in Sub-Sahara Africa. Curr Diab Rep 2014;14:501.
4. Serjeant GR. The natural history of sickle cell disease. Cold Spring Harb Perspect Med 2013;3: A011783.
5. Tripette J, Hardy-Dessources MD, Romana M, et al. Exercise-related complications in sickle cell trait. Clin Hemorheol Microcirc 2013;55: 29-37.
6. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007;110:908-912.
7. Folsom AR, Tang W, Roetker NS, et al. Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost 2015;13:2-9.
8. Caughey MC, Loehr LR, Key NS, et al. Sickle cell trait and incident ischemic stroke in the Atherosclerosis Risk in Communities study. Stroke 2014;45:2863-2867.
9. Naik RP, Derebail VK, Grams ME, et al. Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans. JAMA 2014;312:2115-2125.
10. Baskurt OK, Meiselman HJ, Bergeron MF. Re: Point:Counterpoint: Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity. J Appl Physiol (1985) 2007;103:2142; author reply 2143-2144.
11. Ajayi AA, Kolawole BA. Sickle cell trait and gender influence type 2 diabetic complications in African patients. Eur J Intern Med 2004;15: 312-315.
12. Baskurt OK, Boynard M, Cokelet GC, et al.; International Expert Panel for Standardization of Hemorheological Methods. New guidelines for hemorheological laboratory techniques. Clin Hemorheol Microcirc 2009;42:75-97.
13. Descamps-Latscha B, Witko-Sarsat V. Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl 2001;78: S108-S113.
14. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002;162:221-225.
15. Witko-Sarsat V, Gausson V, Nguyen AT, et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 2003;64: 82-91.
16. Pialoux V, Hanly PJ, Foster GE, et al. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans. Am J Respir Crit Care Med 2009;180:1002-1009.
17. Galinanes M, Matata BM. Protein nitration is predominantly mediated by a peroxynitritedependent pathway in cultured human leucocytes. Biochem J 2002;367:467-473.
18. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15-27.
19. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-16.
20. Corretti MC, Anderson TJ, Benjamin EJ, et al.; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265.
21. Cho YI, Kensey KR. Effects of the non- Newtonian viscosity of blood on flows in a diseased arterial vessel. Part 1: Steady flows. Biorheology 1991;28:241-262.
22. Jeong SK, Rosenson RS. Shear rate specific blood viscosity and shear stress of carotid artery duplex ultrasonography in patients with lacunar infarction. BMC Neurol 2013;13:36.
23. Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2003;29:435-450.
24. Pickering TG, Hall JE, Appel LJ, et al.; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45: 142-161.
25. Lemonne N, Lamarre Y, Romana M, et al. Impaired blood rheology plays a role in the chronic disorders associated with sickle cell-hemoglobin C disease. Haematologica 2014;99:74-75.
26. Ranque B, Menet A, Diop IB, et al. Early renal damage in patients with sickle cell disease in sub-Saharan Africa: A multinational, prospective, cross-sectional study. Lancet Haematol 2014;1:e64-e73.
27. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 2011;57:363-369.
28. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and allcause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-1327.
29. Das SK, Hinds JE, Hardy RE, Collins JC, Mukherjee S. Effects of physical stress on peroxide scavengers in normal and sickle cell trait erythrocytes. Free Radic Biol Med 1993;14:139-147.
30. Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl 2007:S17-S26.
31. Shah AM. Inducible nitric oxide synthase and cardiovascular disease. Cardiovasc Res 2000;45:148-155.
32. Beckman JS, Ye YZ, Chen J, Conger KA. The interactions of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury. Adv Neurol 1996;71:339-350; discussion 350-354.
33. Wautier JL, Zoukourian C, Chappey O, et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 1996; 97:238-243.
34. Heitzer T, Finckh B, Albers S, Krohn K, Kohlschütter A, Meinertz T. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001;31:53-61.
35. Ceriello A, Novials A, Ortega E, et al. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes 2012;61:2993-2997.
36. Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens 2003;17:223-230.
37. Stenvinkel P. Endothelial dysfunction and inflammation-is there a link? Nephrol Dial Transplant 2001;16:1968-1971.
38. Shin S, Ku YH, Ho JX, Kim YK, Suh JS, Singh M. Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus. Clin Hemorheol Microcirc 2007;36:253-261.
39. Tripette J, Connes P, Beltan E, et al. Red blood cell deformability and aggregation, cell adhesion molecules, oxidative stress and nitric oxide markers after a short term, submaximal, exercise in sickle cell trait carriers. Clin Hemorheol Microcirc 2010;45:39-52.